Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Achieve Life Sciences, Inc

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: $156.5M

Website

Clinical Trials

Safety Study of Cytisinicline in Adult Combustible And/or E-cigarette Smokers

Phase 3

Active, not recruiting

Conditions: Vaping Cessation
Smoking Cessation

Interventions: Drug: Cytisinicline

First Posted Date: 2024-05-30

Last Posted Date: 2025-02-26

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 650

Registration Number: NCT06435221

Locations: 🇺🇸
Alliance for Multispecialty Research, LLC, Norfolk, Virginia, United States
🇺🇸
Little Rock Allergy & Asthma Clinical Research Center, Little Rock, Arkansas, United States
🇺🇸
Accel Research Sites Network - DeLand Clinical Research Unit, DeLand, Florida, United States

and more 14 locations

Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Cytisinicline

First Posted Date: 2023-08-08

Last Posted Date: 2023-10-18

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 30

Registration Number: NCT05981768

Locations: 🇵🇹
BlueClinical Phase I, Porto, Portugal

Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

Phase 1

Completed

Conditions: Renal Impairment

Interventions: Drug: cytisinicline

First Posted Date: 2022-11-30

Last Posted Date: 2023-10-19

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 44

Registration Number: NCT05631938

Locations: 🇵🇹
Early Phase Clinical Trials Unit | CHVNG/E + BlueClinical, Gaia, Porto, Portugal
🇵🇹
Hospital de Braga, Centro Clínico Académico Braga, Associação, Braga, Portugal
🇵🇹
BlueClinical Phase I, Porto, Portugal

and more 3 locations

Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Cytisinicline
Drug: Placebo
Drug: Moxifloxacin

First Posted Date: 2022-10-04

Last Posted Date: 2023-05-18

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 27

Registration Number: NCT05566288

Locations: 🇵🇹
BlueClinical Phase I, Porto, Portugal

A Study of Cytisinicline for Vaping Cessation in Adult Smokers

Phase 2

Completed

Conditions: Vaping
E-Cig Use

Interventions: Drug: Placebo
Drug: cytisinicline
Behavioral: Behavioral support

First Posted Date: 2022-06-24

Last Posted Date: 2024-02-28

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 160

Registration Number: NCT05431387

Locations: 🇺🇸
Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States
🇺🇸
Massachusetts General Hospital - Clinical Genetic Research Facility, Boston, Massachusetts, United States
🇺🇸
Rochester Clinical Research, Inc, Rochester, New York, United States

and more 1 locations

A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers

Phase 3

Completed

Conditions: Smoking Cessation

Interventions: Drug: Placebo
Drug: Cytisinicline
Behavioral: Behavioral support

First Posted Date: 2022-01-25

Last Posted Date: 2024-03-19

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 792

Registration Number: NCT05206370

Locations: 🇺🇸
Accel Research Sites - DeLand Clinical Research Unit, DeLand, Florida, United States
🇺🇸
Alliance for Multispecialty Research, LLC, Fort Myers, Florida, United States
🇺🇸
Jacksonville Center for Clinical Research, Jacksonville, Florida, United States

and more 9 locations

A Study of Cytisinicline for Smoking Cessation in Adult Smokers

Phase 3

Completed

Conditions: Smoking Cessation

Interventions: Drug: Placebo
Drug: Cytisinicline
Behavioral: Behavioral support

First Posted Date: 2020-10-06

Last Posted Date: 2024-11-14

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 810

Registration Number: NCT04576949

Locations: 🇺🇸
Alliance for Multispecialty Research, LLC., Knoxville, Tennessee, United States
🇺🇸
Arizona State University, Phoenix, Arizona, United States
🇺🇸
Alliance for Multispecialty Research, LLC, Norfolk, Virginia, United States

and more 8 locations

A Single Dose-escalation Study of Cytisine in Adult Smokers

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: placebo
Drug: cytisine

First Posted Date: 2019-02-20

Last Posted Date: 2020-09-17

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 74

Registration Number: NCT03848208

Locations: 🇵🇹
BlueClinical, Porto, Portugal

Trial of Cytisine in Adult Smokers

Phase 2

Completed

Conditions: Smoking Cessation

Interventions: Drug: Cytisine
Drug: Placebo Comparator
Behavioral: Behavioral support

First Posted Date: 2018-10-17

Last Posted Date: 2020-05-18

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 254

Registration Number: NCT03709823

Locations: 🇺🇸
Clinical Research Consortium, Tempe, Arizona, United States
🇺🇸
Los Angeles Clinical Trials, Burbank, California, United States
🇺🇸
Central Kentucky Research Associates, LLC, Lexington, Kentucky, United States

and more 5 locations

A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: cytisine

First Posted Date: 2018-04-27

Last Posted Date: 2019-09-24

Lead Sponsor: Achieve Life Sciences

Target Recruit Count: 13

Registration Number: NCT03509948

Locations: 🇬🇧
Simbec Research Ltd, Cardiff, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy